ACTREC Project SRF Job – MSc Life Sciences Attend Walk-In
ACTREC Project SRF Job – MSc Life Sciences Attend Walk-In. The Advanced Centre for Treatment, Research, and Education in Cancer (ACTREC) is conducting a walk-in interview for the position of Research Fellow in MSc Life Science. This exciting opportunity offers a chance to contribute to cutting-edge research in the field of life sciences at ACTREC, a renowned institution in the field of cancer research and treatment.
This job expires in
TATA MEMORIAL CENTRE
ADVANCED CENTRE FOR TREATMENT, RESEARCH AND EDUCATION IN CANCER
Kharghar, Navi Mumbai- 410 210
www.actrec.gov.in
Phone No : 91-22-27405000/5082/5353
(A Grant-in-aid Institution of the Dept. of Atomic Energy, Government of India)
No. ACTREC/ADVT-117/2023
WALK – IN – INTERVIEW FOR
Research Fellow: JRF (with minimum one-year experience)/ SRF
(ON PROJECT)
Project Title: The proposed study “Evaluation of the anticancer potential of deuterium depleted water on an experimental mouse model of carcinogen-induced oral and lung cancers” is part of the Heavy Water Board, DAE funded project entitled “Evaluation of the anticancer potential of deuterium depleted water on experimental model systems and clinical trial patients of human breast cancer.”
Duration of the Project: 2 Years
Educational Qualification:
MSc degree (2 years course only) in Life Science or related subjects (Biotechnology, Microbiology, Medical genetics, Lifesciences, Biochemistry, Zoology, etc.). Candidates with M.Sc. degree having a duration of the one-year course will not be considered. This post is for JRF (with minimum one year of experience) and SRF.Experience: Candidates with a minimum of one year of experience in following laboratory techniques/methods only should apply. One year of experience handling lab animals and molecular biology techniques, including western blotting and immunohistochemistry, is strongly required. Candidates should also be proficient in maintaining experimental records using EXCL / SPSS. Candidates familiar with DNA RNA extraction, ELISA, and PCRs (including qPCR) will be given preference.
Consolidated Salary: Rs. 36,400/- per month.
How to Apply:
Candidates may attend the walk-in interview on Monday, 16th October, 2023 in Meeting Room I, Khanolkar Shodhika, ACTREC, Kharghar, Navi Mumbai -410210 along with their CV in the prescribed format only, original and xerox copies of all certificates and testimonials with recent passport size photograph and ID proof (Aadhaar Card).
Reporting Time: 10.00 a.m. to 10.30 a.m.
(Provide your CV details at the time of the interview in the prescribed format only.)
Click here for the notification
Walk-In-Interview for MSc Life Science. The possible interview Q & A to help you with:
Question 1: What is the main objective of your study, and how does it fit into the broader goals of the Heavy Water Board’s funded project?
Answer 1: The main objective of our study is to evaluate the anticancer potential of deuterium-depleted water on experimental mouse models of oral and lung cancers. This research aligns with the broader goals of the Heavy Water Board’s funded project, which aims to assess the potential therapeutic benefits of deuterium-depleted water on various experimental model systems and clinical trial patients, specifically focusing on human breast cancer.
Question 2: Could you explain the significance of deuterium-depleted water in the context of cancer research and how it might impact the treatment of cancer?
Answer 2: Deuterium-depleted water is of interest in cancer research due to its potential to alter the growth and progression of cancer cells. Deuterium, a heavy isotope of hydrogen, can affect various cellular processes. By studying its effects on cancer models, we aim to understand if deuterium-depleted water could offer a novel approach to cancer treatment or prevention.
Question 3: What specific experimental methods or techniques will you be using to evaluate the anticancer potential of deuterium-depleted water in your mouse models?
Answer 3: We will employ a range of experimental techniques, including the administration of deuterium-depleted water to the mouse models, monitoring tumor growth, conducting histopathological analyses, and assessing changes in cellular and molecular markers. These methods will help us gain insights into the impact of deuterium-depleted water on cancer development.
Question 4: Can you briefly explain the expected timeline for this research, from the initiation of the study to the potential dissemination of results?
Answer 4: The timeline for this research will involve several phases, including model establishment, treatment, data collection, and analysis. While the exact duration may vary, we anticipate that the study will take several months. Dissemination of results will follow scientific protocols and may include publication in peer-reviewed journals or presentation at conferences.
Question 5: What are the potential implications of your findings for cancer patients, and how do you plan to translate your research from experimental models to clinical trials with human breast cancer patients?
Answer 5: If our research yields promising results, it could have significant implications for cancer patients by offering a new avenue for therapeutic intervention. To transition from experimental models to clinical trials, we will collaborate with clinical experts and regulatory bodies to design and conduct trials that adhere to ethical and safety standards. This process will involve rigorous testing to ensure the safety and efficacy of deuterium-depleted water as a potential cancer treatment for human breast cancer patients.
Editor’s Note: ACTREC Project SRF Job – MSc Life Sciences Attend Walk-In. Please ensure you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of the latest industry news. Follow us on social media like Twitter, Telegram, Facebook
